Fragmin and Provera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fragmin (dalteparin sodium) and Provera (medroxyprogesterone acetate). Common drug interactions include blood iron increased among females.

The phase IV clinical study analyzes what interactions people have when they take Fragmin and Provera. It is created by eHealthMe based on reports of 32 people who take the same drugs from the FDA, and is updated regularly.

What is Fragmin?

Fragmin has active ingredients of dalteparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 11,999 Fragmin users. Check the latest studies of Fragmin.

What is Provera?

Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.



On Jul, 14, 2026

32 people who take Fragmin and Provera together, and have interactions are studied.

Fragmin and Provera drug interactions.

What are the common drug interactions of Fragmin and Provera, by gender? *:

female:

  1. Blood iron increased
  2. Blood pressure diastolic decreased
  3. Anaemia (lack of blood)
  4. Back pain
  5. Chemotherapy
  6. Endometrial cancer
  7. Metastases to lung (cancer spreads to lung)
  8. Neutropenia (an abnormally low number of neutrophils)
  9. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  10. Surgery

male:

n/a

What are the common drug interactions of Fragmin and Provera, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Abdominal pain
  2. Blood culture positive
  3. Chills (felling of cold)
  4. Colitis (inflammation of colon)
  5. Colitis ulcerative (inflammation of colon with ulcer)
  6. Diarrhoea
  7. Haematochezia (passage of stools containing blood)
  8. Haemoglobin decreased
  9. Malaise (a feeling of general discomfort or uneasiness)
  10. Pain

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetes mellitus inadequate control
  3. Optic neuritis (optic nerve inflammation)
  4. Superior sagittal sinus thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain)

40-49:

n/a

50-59:

  1. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  2. Anaemia (lack of blood)
  3. Back pain
  4. Chemotherapy
  5. Endometrial cancer
  6. Metastases to lung (cancer spreads to lung)
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  9. Surgery
  10. White blood cell count decreased

60+:

  1. Blood iron increased
  2. Blood pressure diastolic decreased
  3. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  4. Hypercapnia (too much smoke)
  5. Hypotension (abnormally low blood pressure)
  6. Hypoxia (low oxygen in tissues)
  7. Nausea (feeling of having an urge to vomit)
  8. Pruritus (severe itching of the skin)
  9. Respiratory distress (difficulty in breathing)
  10. Blood pressure systolic increased

What are the existing conditions these people have? *

  1. Pituitary Tumor: 19 people, 59.38%
  2. Psoriasis (immune-mediated disease that affects the skin): 8 people, 25.00%
  3. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 6.25%
  4. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Fragmin and Provera?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fragmin and Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fragmin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Provera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fragmin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Provera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on dalteparin sodium and medroxyprogesterone acetate (the active ingredients of Fragmin and Provera, respectively), and Fragmin and Provera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: